Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Iranian Journal of Cancer Prevention. 2012; 5 (1): 21-26
Dans Anglais | IMEMR | ID: emr-117540

Résumé

Epidemiologic and molecular evidences have established a strong link between high risk types of Human Papilloma Virus and a subgroup of Head and Neck Squamous Cell Carcinomas [HNSCC]. We evaluated the frequency of HPV positivity in HNSCC and its relationship to demographic and some risk factor variables in an open casecontrol study. Fourteen recently diagnosed patients with squamous cell cancer of oropharynx, hypopharynx and larynx aged 18-50 years were examined from 2008-2010 in Tabriz, Iran. HPV DNA was extracted from paraffin-embedded blocks of each patient's sample for PCR evaluation. Saliva samples of 94 control cancer-free subjects were collected for DNA analysis. Multivariable logistic regression method was used to calculate odds ratio for case-control comparisons. High risk HPV was detected in 6[42.8%] patients, and 6[5.3%] control subjects which was statistically significant [p<0.0001]. HPV-18 was the most frequent type both in the cases and controls. HPV-16 DNA was detected in two patients of the case group, but it was not detected in any of the controls. The relation between demographic and risk factor variables was not statistically significant. HPV infection has a significant impact on HNSCC. Despite HPV-16 stronger impact, HPV-18 is more likely to cause malignant degeneration in such cancers amongst some communities. It is vital to introduce and conduct immunization schedules in health care systems to protect communities to some extent


Sujets)
Humains , Mâle , Femelle , Carcinome épidermoïde/virologie , ADN viral , Tumeurs de la tête et du cou/virologie , Papillomaviridae/isolement et purification , Papillomavirus humain de type 16 , Papillomavirus humain de type 18
2.
Journal of the Faculty of Medicine-Shaheed Beheshti University of Medical Sciences and Health Services. 2007; 31 (3): 233-239
Dans Persan, Anglais | IMEMR | ID: emr-104696

Résumé

Acute Promyelocytic Leukemia, APL, belongs to the group of acute myeloid leukemias. It is distinguished from other types of leukemia by distinct cell morphology, immuno-phenotyping characteristics, coagulopathy and different treatment modalities. The aim of this study was evaluation of the effects of cytologic, clinical and biologic factors specially CD34 expression in determining prognosis in patients with APL. In a descriptive retrospective analysis files of 60 patients with APL were reviewed and data statistically analyzed using SPSS soft ware with Chi Square and T- test. Complete remission and disease free survival [DFS] had no significant correlation with age, sex, WBC, Hemoglobin level, platelet count, purpura, CD34 status, and percentage of blasts in the bone marrow. There was no statistically significant correlation between CD34 expression with morphology, age, sex, WBC, platelet count, percentage of BM blasts and purpura. Cases with CD34 expression had severe anemia, [Hemoglobin=5.8 +/- 1.08], in comparison with patients with CD34 negative APL, [p=0.02]. Results of our study were not concordant with the literature, as recognized prognostic factors had no significant effect on the prognosis of our patients; therefore it is logical to believe that factors influencing the prognosis of APL in Iranian patients may be different. Failure in obtaining complete remission in all 4 patients with CD34+ APL indicates that presence of CD34+ may have been the cause of poor prognosis in these patients. Further studies are necessary to confirm this observation


Sujets)
Humains , Leucémie aiguë promyélocytaire/sang , Leucémie aiguë promyélocytaire/thérapie , Pronostic , Immunophénotypage , Antigènes CD34 , Études rétrospectives , Troubles de l'hémostase et de la coagulation , Induction de rémission , Survie sans rechute
SÉLECTION CITATIONS
Détails de la recherche